{
  "abstractAnalysis": {
    "variants": {
      "E46K": {
        "gene": "α-Synuclein",
        "proteinChange": "Glu 46 to Ala",
        "variantString": "α-Syn 46K",
        "pathogenicityStrength": "PS3_supporting"
      },
      "A53T": {
        "gene": "α-Synuclein",
        "proteinChange": "Glu 53 to Tyrosine",
        "variantString": "α-Syn 53T",
        "pathogenicityStrength": "PS3_very_strong"
      }
    },
    "flowchartSteps": {
      "E46K": {
        "step1": "Yes (mutation affects amyloid fibril formation)",
        "step2": "Applicable (assay type matches disease mechanism)",
        "step3a": "No controls mentioned",
        "step3b": "No data on replicates or controls",
        "step4c": {
          "oddsPathInferred": "High (PS3_very_strong)"
        }
      },
      "A53T": {
        "step1": "Yes (stronger mutation effect)",
        "step2": "Applicable (assay type matches disease mechanism)",
        "step3a": "No controls mentioned",
        "step3b": "No data on replicates or controls",
        "step4c": {
          "oddsPathInferred": "Very high (PS3_very_strong)"
        }
      }
    },
    "interpretationComments": {
      "E46K": "The variant has a significant but moderate effect, consistent with the observed impact on amyloid fibril formation.",
      "A53T": "The strongest mutation tested, with evidence of a very strong pathogenic effect."
    }
  }
}